CY1121598T1 - Ανθελονοσιακες ενωσεις με ευελικτες πλευρικες αλυσιδες - Google Patents
Ανθελονοσιακες ενωσεις με ευελικτες πλευρικες αλυσιδεςInfo
- Publication number
- CY1121598T1 CY1121598T1 CY20191100432T CY191100432T CY1121598T1 CY 1121598 T1 CY1121598 T1 CY 1121598T1 CY 20191100432 T CY20191100432 T CY 20191100432T CY 191100432 T CY191100432 T CY 191100432T CY 1121598 T1 CY1121598 T1 CY 1121598T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compounds
- antifinal
- side chains
- flexible side
- present
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 108010022394 Threonine synthase Proteins 0.000 abstract 2
- 102000004419 dihydrofolate reductase Human genes 0.000 abstract 2
- 201000004792 malaria Diseases 0.000 abstract 2
- 241000223960 Plasmodium falciparum Species 0.000 abstract 1
- 230000000078 anti-malarial effect Effects 0.000 abstract 1
- 239000003430 antimalarial agent Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97837507P | 2007-10-08 | 2007-10-08 | |
| PCT/US2008/079210 WO2009048957A1 (en) | 2007-10-08 | 2008-10-08 | Antimalarial compounds with flexible side-chains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1121598T1 true CY1121598T1 (el) | 2020-07-31 |
Family
ID=40534843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100432T CY1121598T1 (el) | 2007-10-08 | 2019-04-19 | Ανθελονοσιακες ενωσεις με ευελικτες πλευρικες αλυσιδες |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8530491B2 (enExample) |
| EP (2) | EP3546452A1 (enExample) |
| JP (1) | JP5603775B2 (enExample) |
| KR (1) | KR101578949B1 (enExample) |
| CN (1) | CN101820879B (enExample) |
| AU (1) | AU2008310898B2 (enExample) |
| BR (1) | BRPI0818618B8 (enExample) |
| CA (1) | CA2700880C (enExample) |
| CY (1) | CY1121598T1 (enExample) |
| DK (1) | DK2194985T3 (enExample) |
| ES (1) | ES2727015T3 (enExample) |
| HR (1) | HRP20190589T1 (enExample) |
| HU (1) | HUE044398T2 (enExample) |
| LT (1) | LT2194985T (enExample) |
| MX (1) | MX2010003739A (enExample) |
| PL (1) | PL2194985T3 (enExample) |
| PT (1) | PT2194985T (enExample) |
| RU (1) | RU2485107C2 (enExample) |
| SI (1) | SI2194985T1 (enExample) |
| TR (1) | TR201904913T4 (enExample) |
| UA (1) | UA105759C2 (enExample) |
| WO (1) | WO2009048957A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9611503B2 (en) | 2011-02-09 | 2017-04-04 | National Science And Technology Development Agency | Escherichia coli cell line with thyA knockout and folA knockout |
| WO2012121682A2 (en) * | 2011-03-10 | 2012-09-13 | National Science And Technology Development Agency | Anti-folate antimalarials with dual-binding modes and their preparation |
| US10011842B2 (en) | 2013-09-30 | 2018-07-03 | National Science And Technology Development Agency | Escherichia coli cell line with thyA knockout, folA knockout, and one or both of folP knockout, and folK knockout |
| CN104593406A (zh) * | 2015-01-08 | 2015-05-06 | 山西医科大学 | pIRES/TgDHFR-TS真核表达重组质粒及其构建和应用 |
| US11028072B2 (en) | 2015-09-23 | 2021-06-08 | National Science And Technology Development Agency | 2,4-diamino-6-ethylpyrimidine derivatives with antimalarial activities against Plasmodium falciparum |
| CN106083742A (zh) * | 2016-05-31 | 2016-11-09 | 广东工业大学 | 一种2,4‑二胺基喹唑啉衍生物及其制备方法和应用 |
| WO2021155748A1 (en) * | 2020-02-04 | 2021-08-12 | Tsinghua University | Inhibitors of malarial and plasmodium falciparum hexose transporter and uses thereof |
| CN112961106A (zh) * | 2021-03-13 | 2021-06-15 | 德州学院 | 一种4-羟基-6氯喹啉合成新工艺 |
| EP4438596A1 (en) * | 2023-03-28 | 2024-10-02 | Université de Lille | Diaminopyrimidine derivatives as hdac and dhfr dual-targeting inhibitors and use thereof in preventing and treating malaria |
| WO2025053796A1 (en) * | 2023-09-04 | 2025-03-13 | National Science And Technology Development Agency | Hybrid molecules between pyrimidine derivatives and idasanutlin |
| CN117025299A (zh) * | 2023-09-07 | 2023-11-10 | 中国烟草总公司郑州烟草研究院 | 一种烟用豆香香基模块、香精和卷烟 |
| CN117263804A (zh) * | 2023-09-07 | 2023-12-22 | 中国烟草总公司郑州烟草研究院 | 邻羟基苯丙酸酯及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4033962A (en) * | 1975-06-26 | 1977-07-05 | Hoffman-La Roche Inc. | 2,4-Diamino-pyrimidine derivatives and processes |
| GB1546937A (en) * | 1976-07-29 | 1979-05-31 | Beecham Group Ltd | 2,4-diaminopyrimidine derivatives |
| FR2397407A2 (fr) | 1977-07-11 | 1979-02-09 | Dick Pierre | Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides |
| OA07362A (fr) | 1980-10-27 | 1984-06-30 | May & Baker Ltd | Dérivés de la pyrimidine, leur procédé de préparation et les compositions les contenant. |
| GB2086386B (en) | 1980-10-27 | 1984-01-18 | May & Baker Ltd | Pyrimidine derivatives |
| US5322858A (en) | 1992-02-14 | 1994-06-21 | Jacobus Pharmaceutical Co. Inc. | N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines |
| RU95113597A (ru) * | 1992-12-02 | 1997-06-10 | ФМК Корпорейшн (US) | Инсектицидная композиция, способы борьбы с насекомыми |
| KR20020008197A (ko) * | 1999-05-24 | 2002-01-29 | 가와무라 요시부미 | 항-Ｆａｓ 항체를 함유하는 의약 조성물 |
| IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
| US7371758B2 (en) | 2003-03-13 | 2008-05-13 | National Science & Technology Development Agency | Antimalarial pyrimidine derivatives and methods of making and using them |
-
2008
- 2008-10-08 RU RU2010117193/04A patent/RU2485107C2/ru active
- 2008-10-08 EP EP19157867.3A patent/EP3546452A1/en not_active Withdrawn
- 2008-10-08 US US12/247,953 patent/US8530491B2/en active Active
- 2008-10-08 HU HUE08837766 patent/HUE044398T2/hu unknown
- 2008-10-08 UA UAA201004117A patent/UA105759C2/uk unknown
- 2008-10-08 AU AU2008310898A patent/AU2008310898B2/en not_active Ceased
- 2008-10-08 WO PCT/US2008/079210 patent/WO2009048957A1/en not_active Ceased
- 2008-10-08 SI SI200832053T patent/SI2194985T1/sl unknown
- 2008-10-08 JP JP2010528223A patent/JP5603775B2/ja not_active Expired - Fee Related
- 2008-10-08 ES ES08837766T patent/ES2727015T3/es active Active
- 2008-10-08 TR TR2019/04913T patent/TR201904913T4/tr unknown
- 2008-10-08 CN CN2008801106805A patent/CN101820879B/zh active Active
- 2008-10-08 CA CA2700880A patent/CA2700880C/en active Active
- 2008-10-08 PT PT08837766T patent/PT2194985T/pt unknown
- 2008-10-08 LT LTEP08837766.8T patent/LT2194985T/lt unknown
- 2008-10-08 PL PL08837766T patent/PL2194985T3/pl unknown
- 2008-10-08 MX MX2010003739A patent/MX2010003739A/es active IP Right Grant
- 2008-10-08 HR HRP20190589TT patent/HRP20190589T1/hr unknown
- 2008-10-08 BR BRPI0818618A patent/BRPI0818618B8/pt active IP Right Grant
- 2008-10-08 KR KR1020107010151A patent/KR101578949B1/ko active Active
- 2008-10-08 DK DK08837766.8T patent/DK2194985T3/da active
- 2008-10-08 EP EP08837766.8A patent/EP2194985B1/en active Active
-
2019
- 2019-04-19 CY CY20191100432T patent/CY1121598T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010003739A (es) | Compuestos anti-malaria con cadenas laterales flexibles. | |
| CY1126771T1 (el) | Συνδυασμοι δολουτεγραβιρης και λαμιβουδινης για την αγωγη λοιμωξης απο hiv | |
| CY1120994T1 (el) | Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων | |
| EA201200631A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| MA32316B1 (fr) | Derives spiro-indoles pour le traitement de maladies parasitaires | |
| CY1107419T1 (el) | Προφαρμακα αντι-ιικων μεσων απο πιπεραζινη και υποκατεστημενη πιπεριδινη | |
| CY1110266T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις ως αναστολεις της hiv ιντεγκρασης | |
| CY1120081T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
| CY1109775T1 (el) | Κρυσταλλικες μορφες μιας διφαινυλικης ενωσης | |
| CY1118454T1 (el) | Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες | |
| CY1117728T1 (el) | Στερεες μορφες 3-(6-(1-(2,2-διφθοροβενζο[d][1,3]διοξολ-5-υλ) κυκλοπροπανοκαρβοξαμιδο)-3-μεθυλπυριδιν-2-υλ)βενζοϊκου οξεος | |
| CY1119232T1 (el) | Ενα διφαινυλοσουλφοναμιδιο ανταγωνιστης του υποδοχεα της ενδοθηλινης και της αγγειοτενσινης ii για τη θεραπεια της σπειραματοσκληρυνσης | |
| CY1114981T1 (el) | Προφαρμακα ντολουτεγκραβιρης | |
| CY1118227T1 (el) | Διαμορφωτες φαρμακοκινητικων ιδιοτητων θεραπευτικων παραγοντων | |
| CR20120397A (es) | Inhibidores del virus de la hepatitis c | |
| EA201101620A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| CY1110665T1 (el) | Αναστολεις hiv ιντεγκρασης | |
| CY1109010T1 (el) | γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ | |
| CY1115381T1 (el) | Διενυδρη υδροχλωρικη ναλμεφαινη | |
| CY1115585T1 (el) | Κρυσταλλικες μορφες του αλατος του νατριου της 5-αμινο-2,3-διυδροφθαλαζιν-1,4-διονης, οι οποιες περιεχουν φαρμακευτικα σκευασματα και διαδικασιες για την παρασκευη τους | |
| CY1117584T1 (el) | Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, cx3cr1 | |
| CY1112451T1 (el) | Μεθοδος για μειωση γαστρεντερικης τοξικοτητας λογω της χορηγησης τεγκαφουρης | |
| CY1112019T1 (el) | Αγωνιστες υποδοχεων νιασινης, συνθεσεις που περιεχουν τετοιες ενωσεις και μεθοδοι θεραπειας | |
| MA32812B1 (fr) | Composition pharmaceutique d'un inhibiteur puissant du vhc pour une administration orale | |
| CY1113240T1 (el) | Αλατα ενωσεων αναστολεα hiv |